Stability Indication: 열적, 물리적, 화학적, 구조적 안정성 특성 평가를 통해 단백질의 고유 특성을 규명한다.
Excipient Selection: 단백질 안정성에 영향을 미치는 부형제 및 제형 성분 간 상호작용을 평가하기 위해 통계적 실험계획법(DOE)을 활용한다.
Dosage Form: 분석·공정·제형 개발의 글로벌 파트너로서 데이터 기반의 견고한 바이오의약품 제형을 개발한다.

기타 정보

추가 설명:

This formulation development approach pairs two complementary disciplines: building a comprehensive understanding of a protein's intrinsic properties and stability through thermal, physical, chemical and conformational characterization, and evaluating interactions and key effects on protein stability using statistical design of experiments (DOE). This lets KBI develop robust formulations by removing uncontrolled stability variables, focusing on therapeutic performance and clinical outcomes, drawing on more than 130 successful protein, peptide and vaccine formulation development programs and delivering stable liquid formulations across protein concentrations from above 1 mg/mL to 200 mg/mL.